Skip to main content

Levoleucovorin Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Jul 4, 2022.

Levoleucovorin is also known as: Fusilev, Khapzory

Levoleucovorin Pregnancy Warnings

Animal studies have not been conducted. There are no controlled data in human pregnancy. It is unknown if this drug can cause fetal harm or affect reproduction capacity.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Use is not recommended unless clearly needed.

US FDA pregnancy category: C

See references

Levoleucovorin Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

See references

References for pregnancy information

  1. "Product Information. Levoleucovorin (levoleucovorin)." Spectrum Chemical (2008):

References for breastfeeding information

  1. "Product Information. Levoleucovorin (levoleucovorin)." Spectrum Chemical (2008):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.